Our institution has also reported on the usefulness of PET using 11C-methionine (MET), 11C-choline (CHO), and 18F-fluorodeoxyglucose (FDG) for differentiating among gliomas (particularly those with IDH mutations) [7,8]. Here, IDH1 is linked to central nervous system cancer.